Furthermore, significantly higher concentrations of phospho-NF-κB were identified in the kidneys of the CIS-treated Gal-3 wild-type mice compared to the CIS-treated Gal-3 KO mice, showing statistical significance (p < 0.001) (Figure 11A). Here, NFKB1 is linked to in situ carcinoma.